Viamer Biosciences

Viamer Biosciences is a private U.S. biomaterials and medical technology company developing bioresorbable polymer materials for regenerative medicine, local drug delivery, medical devices, and biomedical 3D manufacturing. The company appears to operate under or formerly used the name 21MedTech and centers its technology around CYPREX, a patented poly(ester urea)-based biomaterial platform. Its materials are designed to provide tunable chemistry, physical properties, resorption profiles, and controlled drug-release behavior for implantable and tissue-regeneration applications. Publicly visible information suggests the company is primarily a platform and materials developer rather than a late-stage therapeutics company, with programs still at the preclinical or product-development stage. Viamer has also entered at least one licensing arrangement to enable third-party product development in dental barrier membranes and related bone-regeneration applications.